Evidence map›Paper›PMID 38026972›Full record

ArticleFrontiers in pharmacology2023

Shikimic acid (SA) inhibits neuro-inflammation and exerts neuroprotective effects in an LPS-induced

Xueying Bao, Zhuangzhuang Zheng, Jincai Lv, Jindian Bao, Sitong Chang, Xin Jiang, Ying Xin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Alleviating Effects of Ethanol Extract fromAntioxidants (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Chemical Analysis of SU-Eohyeol Pharmacopuncture and ItsInternational journal of medical sciences · 2024
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xueying BaoDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Zhuangzhuang ZhengDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Jincai LvDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Jindian BaoDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Sitong ChangDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Xin JiangDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Ying XinKey Laboratory of Pathobiology, Ministry of Education, and College of Basic Medical Science, Jilin University, Changchun, China.
Jilin University · CNFirst Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous studies have shown that neuroinflammation is involved in the process of neuronal damage in neurodegenerative diseases such as Parkinson's disease (PD), for example, and that inhibiting neuroinflammation help improve PD. Shikimic acid (SA) has anti-inflammatory, analgesic and antioxidant activities in numerous diseases. However, its effect and mechanism in PD remain unclear. In this experiment, we found that SA inhibits production of pro-inflammatory mediators and ROS in LPS-induced BV2 cells. Mechanistic studies demonstrated that SA suppresses neuro-inflammation by activating the AKT/Nrf2 pathway and inhibiting the NF-κB pathway. Further

Indexed as

microglianeuro-inflammationneuroprotectionparkinson’s diseaseshikimic acid

Identifiers

PMID38026972
PMCPMC10652795
OpenAlexW4388216968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.